Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $155.1 million.

  • GeneDx Holdings' Cash & Current Investments rose 3316.07% to $155.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.1 million, marking a year-over-year increase of 3316.07%. This contributed to the annual value of $141.2 million for FY2024, which is 848.03% up from last year.
  • Per GeneDx Holdings' latest filing, its Cash & Current Investments stood at $155.1 million for Q3 2025, which was up 3316.07% from $134.6 million recorded in Q2 2025.
  • Over the past 5 years, GeneDx Holdings' Cash & Current Investments peaked at $461.3 million during Q3 2021, and registered a low of $26.5 million during Q2 2021.
  • Moreover, its 5-year median value for Cash & Current Investments was $141.2 million (2024), whereas its average is $179.1 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first surged by 4036355.24% in 2021, then tumbled by 6906.08% in 2022.
  • Quarter analysis of 5 years shows GeneDx Holdings' Cash & Current Investments stood at $400.6 million in 2021, then crashed by 69.06% to $123.9 million in 2022, then increased by 5.01% to $130.1 million in 2023, then grew by 8.48% to $141.2 million in 2024, then increased by 9.84% to $155.1 million in 2025.
  • Its last three reported values are $155.1 million in Q3 2025, $134.6 million for Q2 2025, and $159.2 million during Q1 2025.